| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
, and Ceramide1
Department of Radiation and Cellular Oncology [M. C., R. R. W.], Department of Pathology, Committee on Immunology [J. Q.], and Department of Medicine and Howard Hughes Institute [C. T.], University of Chicago, Chicago, Illinois 60637; Department of Radiation Therapy, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 [Z. F.]; and Laboratory of Pharmacology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115 [D. W. K.]
Recent studies have proposed that tumor necrosis factor
(TNF-
) and ionizing radiation induce apoptosis by activating hydrolysis of sphingomyelin to ceramide. Bcl-2 and a related gene, Bcl-X, inhibit several forms of apoptosis. Herein, we report that internucleosomal DNA fragmentation, characteristic of apoptosis and induced by ionizing radiation, is accompanied by concomitant decreases in Bcl-2 and Bcl-X mRNA levels in HL-60 and U-937 human leukemia cells. Apoptotic DNA fragmentation after exposure to TNF-
and C2-ceramide was also associated with down-regulation of Bcl-2 mRNA in HL-60 and U-937 cells, while Bcl-X mRNA production was unaffected. These results suggest that modulation of Bcl-2 gene expression may be a target for ceramide-mediated apoptosis following exposure to ionizing radiation and TNF-
. Changes in Bcl-2 expression may be the basis for the interactive killing observed between radiation and TNF-
in some human and tumor cells.
1 Supported by NIH/National Cancer Institute Grants CA42596 and CA55241.
2 To whom requests for reprints should be addressed, at Department of Radiation and Cellular Oncology, University of Chicago, S841 South Maryland Avenue, Box 442, Chicago, IL 60637.
Received 12/22/94. Accepted 1/27/95.
This article has been cited by other articles:
![]() |
S. Dey, P. M. Spring, S. Arnold, J. Valentino, D. Chendil, W. F. Regine, M. Mohiuddin, and M. M. Ahmed Low-Dose Fractionated Radiation Potentiates the Effects of Paclitaxel in Wild-type and Mutant p53 Head and Neck Tumor Cell Lines Clin. Cancer Res., April 1, 2003; 9(4): 1557 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Lawrence, M. A. Davis, A. Hough, and A. Rehemtulla The Role of Apoptosis in 2',2'-Difluoro-2'-deoxycytidine (Gemcitabine)-mediated Radiosensitization Clin. Cancer Res., February 1, 2001; 7(2): 314 - 319. [Abstract] [Full Text] |
||||
![]() |
L. A. Peña, Z. Fuks, and R. N. Kolesnick Radiation-induced Apoptosis of Endothelial Cells in the Murine Central Nervous System: Protection by Fibroblast Growth Factor and Sphingomyelinase Deficiency Cancer Res., January 1, 2000; 60(2): 321 - 327. [Abstract] [Full Text] |
||||
![]() |
N. SCHIAVONE, P. ROSINI, A. QUATTRONE, M. DONNINI, A. LAPUCCI, L. CITTI, A. BEVILACQUA, A. NICOLIN, and S. CAPACCIOLI A conserved AU-rich element in the 3' untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis FASEB J, January 1, 2000; 14(1): 174 - 184. [Abstract] [Full Text] |
||||
![]() |
G.-J. Zhang, I. Kimijima, M. Onda, M. Kanno, H. Sato, T. Watanabe, A. Tsuchiya, R. Abe, and S. Takenoshita Tamoxifen-induced Apoptosis in Breast Cancer Cells Relates to Down-Regulation of bcl-2, but not bax and bcl-XL, without Alteration of p53 Protein Levels Clin. Cancer Res., October 1, 1999; 5(10): 2971 - 2977. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Alexander-Miller, M. A. Derby, A. Sarin, P. A. Henkart, and J. A. Berzofsky Supraoptimal Peptide-Major Histocompatibility Complex Causes a Decrease in Bcl-2 Levels and Allows Tumor Necrosis Factor alpha Receptor II-mediated Apoptosis of Cytotoxic T Lymphocytes J. Exp. Med., October 19, 1998; 188(8): 1391 - 1399. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-p. Jaffrézou, N. Maestre, V. D. Mas-mansat, C. Bezombes, T. Levade, and G. Laurent Positive feedback control of neutral sphingomyelinase activity by ceramide FASEB J, August 1, 1998; 12(11): 999 - 1006. [Abstract] [Full Text] |
||||
![]() |
L Garcia-Bermejo, C Perez, N. Vilaboa, E de Blas, and P Aller cAMP increasing agents attenuate the generation of apoptosis by etoposide in promonocytic leukemia cells J. Cell Sci., January 3, 1998; 111(5): 637 - 644. [Abstract] [PDF] |
||||
![]() |
C. Bezombes, N. Maestre, G. Laurent, T. Levade, A. Bettaïeb, and J.-p. Jaffrézou Restoration of TNF-{alpha}-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833 FASEB J, January 1, 1998; 12(1): 101 - 109. [Abstract] [Full Text] |
||||
![]() |
S. P. Whitman, F. Civoli, and L. W. Daniel Protein Kinase Cbeta II Activation by 1-beta -D-Arabinofuranosylcytosine Is Antagonistic to Stimulation of Apoptosis and Bcl-2alpha Down-regulation J. Biol. Chem., September 19, 1997; 272(38): 23481 - 23484. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Quillet-Mary, J.-P. Jaffrezou, V. Mansat, C. Bordier, J. Naval, and G. Laurent Implication of Mitochondrial Hydrogen Peroxide Generation in Ceramide-induced Apoptosis J. Biol. Chem., August 22, 1997; 272(34): 21388 - 21395. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Findley, L. Gu, A. M. Yeager, and M. Zhou Expression and Regulation of Bcl-2, Bcl-xl, and Bax Correlate With p53 Status and Sensitivity to Apoptosis in Childhood Acute Lymphoblastic Leukemia Blood, April 15, 1997; 89(8): 2986 - 2993. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |